OBJECTIVES: The present study was designed to 1) validate the use of UBM for non-invasive monitoring of grafts/implants over-time, and to 2) correlate UBM findings with the morphological attributes of recovered grafts/implants.
MATERIALS AND METHODS: Testis tissue fragments (~14 mm3 , each) and cell aggregates (100×106 cells, each) obtained from 1-wk-old donor piglets (n = 30) were grafted/implanted under the back skin of immunodeficient mice (n = 6) in eight analogous sites per mouse. Three-dimensional transcutaneous Doppler UBM was performed and a randomly-selected graft and its corresponding implant were recovered at 2, 4, 6, and 8 wk.
RESULTS: Graft/implant weight (p = 0.04) and physical height (p = 0.03) increased over-time. The dynamics of physical length and volume increases over time differed between tissue grafts and cell implants (p = 0.02 and 0.01 for sample type*time interactions, respectively). UBM-estimated volume was correlated with the post-recovery weight and volume of the grafts/implants (r = 0.98 and r = 0.99, respectively; p < 0.001). Pre- and post-recovery length and height of the grafts/implants were positively and strongly correlated (r = 0.50, p = 0.01; r = 0.70, p = 0.001) and so were the areas covered by cordal, non-cordal or fluid-filled cavities between UBM and histology (r = 0.87, p < 0.001).
DISCUSSION AND CONCLUSION: UBM findings correlated with physical attributes of the grafts/implants, validating its use as a non-invasive high-fidelity tool to quantify the developmental changes in ectopic testis tissue grafts and cell implants, potentially leading to a reduction in the number of recipient mice needed for similar experiments.
METHODS: The polyphenolic compounds in SCFE were identified with Reverse phase-high performance liquid chromatography (RP-HPLC). Meanwhile, murine 3T3-L1 preadipocytes, measuring leptin levels, reactive oxygen species (ROS), and lipid and triglyceride (TG) contents were utilized during anti-adipogenic activity assessments. Concurrently, the effects of SCFE on adipogenic transcription factors were established with quantitative real-time-polymerase chain reaction (qRT-PCR).
RESULTS: The RP-HPLC results indicated three polyphenolic compounds in SCFE, including one flavonoid (naringin) and two phenolic acids (syringic and p-coumaric). Although SCFE treatments (250-1000 μg/mL) did not result in cell toxicity, they significantly reduced dose-dependent lipid accumulation, ROS production, and TG and leptin levels relative to control-differentiated adipocytes. Moreover, SCFE suppressed sterol regulatory element binding protein-1 (SREBP-1), peroxisome proliferator-activated receptor-gamma (PPAR-γ), and CCAAT/enhancer-binding protein-alpha (C/EBP-α) gene expressions during preadipocyte differentiation into adipocytes.
CONCLUSION: The findings revealed the anti-adipogenic properties of SCFE, indicating its potential as a natural obesity management remedy. Nevertheless, more studies are necessary to elucidate the reactions resulting in SCFE anti-adipogenic effects and the active constituents responsible for the property.